Quantcast

Latest German inventions Stories

2011-06-23 15:00:00

SAN CARLOS, Calif., June 23, 2011 /PRNewswire/ -- PharmacoFore, Inc., a privately held biopharmaceutical company developing next-generation abuse-resistant prescription drugs, today announced positive results from a Phase I human proof-of-concept (hPOC) study of its hydromorphone (HM) Bio-Activated Molecular Delivery(TM) (Bio-MD(TM)) product candidate, PF329. Greg Sturmer, VP, Finance and CFO, will present at the 2011 BIO Business Forum during the annual BIO International Convention at the...

2011-06-13 13:34:24

Risky behavior, psychiatric disorders, substance abuse contribute to opioid overdose Deaths related to prescription opioid therapy are under intense scrutiny, prompting those in pain medicine"”clinicians, patient advocates, and regulators"”to understand the causes behind avoidable mortality in legitimately treated patients. Studies reporting on statistics, causes, and adverse events involving opioid treatment are now available in a special supplement of Pain Medicine, a journal...

2011-06-07 08:00:00

SAN FRANCISCO, June 7, 2011 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) announced today positive interim data from an ongoing single-dose Phase 1 clinical trial evaluating NKTR-181, the company's novel mu-opioid analgesic candidate. Interim study results show that the molecule achieved its study objectives with an extended PK profile, slow entry into the CNS, and analgesic response. This interim data also show that the drug candidate exhibits an excellent safety and tolerability...

2011-06-07 07:00:00

SAN DIEGO, June 7, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced today that OFIRMEV® (acetaminophen) injection has been added to the U.S. Department of Defense's Joint Deployment Formulary (JDF), the core list of pharmaceutical products required for theater-level care of deployed forces. The U.S. Food and Drug Administration (FDA) approved OFIRMEV in November 2010 for the management of mild to moderate pain, the management of moderate to...

2011-05-31 06:30:00

REDWOOD CITY, Calif., May 31, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)(AcelRx), today announced that the US Army Medical Research and Material Command (USAMRMC) has awarded AcelRx a $5.6 million grant to support the development of a new product candidate, ARX-04, a proprietary non-invasive, fast-onset sublingual product for the treatment of moderate-to-severe acute pain. Commenting on the award, Richard King, AcelRx President and Chief Executive Officer stated,...

2011-05-25 06:44:40

(Ivanhoe Newswire) "“ For the first time scientists have accomplished a laboratory synthesis of a rare natural product isolated from the bark of a plant widely employed in traditional medicine. This advance may provide the scientific foundation to develop an effective alternative to commonly prescribed narcotic pain treatments. The study defines a chemical means to access meaningful quantities of the rare natural product conolidine. Based on data from mouse models, the study also...

2011-05-24 07:33:00

NORTH LIBERTY, Iowa, May 24, 2011 /PRNewswire/ -- KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of its most advanced opioid-based drug candidate, KP201, a novel hydrocodone prodrug for treating pain. KP201 is a new chemical entity (NCE) composed of hydrocodone chemically bound to a ligand. The data confirmed that KP201 is cleaved in man as predicted, releasing the active pharmaceutical compound hydrocodone into the bloodstream at amounts equivalent to the...

2011-05-23 14:06:07

Novel compound could become an alternative to problematic narcotic analgesics Scientists from the Florida campus of The Scripps Research Institute have for the first time accomplished a laboratory synthesis of a rare natural product isolated from the bark of a plant widely employed in traditional medicine. This advance may provide the scientific foundation to develop an effective alternative to commonly prescribed narcotic pain treatments. The study, published May 23, 2011, in an advanced...

2011-05-23 11:44:00

Novel Compound Could Become an Alternative to Problematic Narcotic Analgesics JUPITER, Fla., May 23, 2011 /PRNewswire-USNewswire/ -- Scientists from the Florida campus of The Scripps Research Institute have for the first time accomplished a laboratory synthesis of a rare natural product isolated from the bark of a plant widely employed in traditional medicine. This advance may provide the scientific foundation to develop an effective alternative to commonly prescribed narcotic pain...

2011-05-18 14:02:00

Makers of Over-the-Counter Single-Ingredient Pediatric Acetaminophen Products Already Taking Action to Help Parents Accurately Dose and Safely Store Medicines WASHINGTON, May 18, 2011 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA), representing makers of over-the-counter (OTC) single-ingredient acetaminophen medicines for children, applauds the U.S. Food and Drug Administration (FDA) efforts to help parents and caregivers give their children the right...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related